These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33485619)

  • 1. Impact of cancer center accreditation on outcomes of patients undergoing resection for hepatocellular carcinoma: A SEER-Medicare analysis.
    Tsilimigras DI; Hyer JM; Diaz A; Moris D; Abbas A; Dillhoff M; Cloyd JM; Ejaz A; Beane JD; Tsung A; Pawlik TM
    Am J Surg; 2021 Sep; 222(3):570-576. PubMed ID: 33485619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in long-term oncologic outcomes by type of cancer center accreditation: An analysis of a SEER-Medicare population with pancreatic cancer.
    Fong ZV; Chang DC; Hur C; Jin G; Tramontano A; Sell NM; Warshaw AL; Fernandez-Del Castillo C; Ferrone CR; Lillemoe KD; Qadan M
    Am J Surg; 2020 Jul; 220(1):29-34. PubMed ID: 32265013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Access to Accredited Cancer Hospitals Within Federal Exchange Plans Under the Affordable Care Act.
    Kehl KL; Liao KP; Krause TM; Giordano SH
    J Clin Oncol; 2017 Feb; 35(6):645-651. PubMed ID: 28068172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Dedicated Cancer Centers on Outcomes Among Medicare Beneficiaries Undergoing Liver and Pancreatic Cancer Surgery.
    Mehta R; Ejaz A; Hyer JM; Tsilimigras DI; White S; Merath K; Sahara K; Bagante F; Paredes AZ; Cloyd JM; Dillhoff M; Tsung A; Pawlik TM
    Ann Surg Oncol; 2019 Nov; 26(12):4083-4090. PubMed ID: 31376033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between cancer center accreditation and performance on publicly reported quality measures.
    Merkow RP; Chung JW; Paruch JL; Bentrem DJ; Bilimoria KY
    Ann Surg; 2014 Jun; 259(6):1091-7. PubMed ID: 24509202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dedicated Cancer Centers are More Likely to Achieve a Textbook Outcome Following Hepatopancreatic Surgery.
    Mehta R; Tsilimigras DI; Paredes AZ; Sahara K; Dillhoff M; Cloyd JM; Ejaz A; White S; Pawlik TM
    Ann Surg Oncol; 2020 Jun; 27(6):1889-1897. PubMed ID: 32108924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes after resection of alcohol-related versus hepatitis-related hepatocellular carcinoma: A SEER-Medicare database analysis.
    Mehta R; Tang Qinghe ; Tsilimigras DI; Paredes A; Dillhoff M; Cloyd JM; Ejaz A; Tsung A; Spolverato G; Pawlik TM
    Am J Surg; 2021 Jul; 222(1):167-172. PubMed ID: 33131693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do cancer centers designated by the National Cancer Institute have better surgical outcomes?
    Birkmeyer NJ; Goodney PP; Stukel TA; Hillner BE; Birkmeyer JD
    Cancer; 2005 Feb; 103(3):435-41. PubMed ID: 15622523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of National Cancer Institute-designated cancer center status: observed variation in surgical care depends on the level of evidence.
    In H; Neville BA; Lipsitz SR; Corso KA; Weeks JC; Greenberg CC
    Ann Surg; 2012 May; 255(5):890-5. PubMed ID: 22504278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Facility Type and Surgical Volume on 10-Year Survival in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma.
    Chapman BC; Paniccia A; Hosokawa PW; Henderson WG; Overbey DM; Messersmith W; McCarter MD; Gleisner A; Edil BH; Schulick RD; Gajdos C
    J Am Coll Surg; 2017 Mar; 224(3):362-372. PubMed ID: 27923615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National Cancer Institute designation predicts improved outcomes in colorectal cancer surgery.
    Paulson EC; Mitra N; Sonnad S; Armstrong K; Wirtalla C; Kelz RR; Mahmoud NN
    Ann Surg; 2008 Oct; 248(4):675-86. PubMed ID: 18936581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis.
    Berardi G; Morise Z; Sposito C; Igarashi K; Panetta V; Simonelli I; Kim S; Goh BKP; Kubo S; Tanaka S; Takeda Y; Ettorre GM; Wilson GC; Cimino M; Chan CY; Torzilli G; Cheung TT; Kaneko H; Mazzaferro V; Geller DA; Han HS; Kanazawa A; Wakabayashi G; Troisi RI
    J Hepatol; 2020 Jan; 72(1):75-84. PubMed ID: 31499131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival outcomes of liver transplantation versus liver resection among patients with hepatocellular carcinoma: A SEER-based longitudinal study.
    Zhang K; Chen R; Gong X; Gao Y
    J Formos Med Assoc; 2019 Apr; 118(4):790-796. PubMed ID: 30482570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation versus surgical resection of hepatocellular carcinoma: contemporary treatment trends and outcomes from the United States National Cancer Database.
    Uhlig J; Sellers CM; Stein SM; Kim HS
    Eur Radiol; 2019 May; 29(5):2679-2689. PubMed ID: 30560364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of national hospital accreditation in bariatric surgery on perioperative outcomes and long-term mortality.
    Telem DA; Talamini M; Altieri M; Yang J; Zhang Q; Pryor AD
    Surg Obes Relat Dis; 2015; 11(4):749-57. PubMed ID: 26001555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative and cost effectiveness of treatment modalities for hepatocellular carcinoma in SEER-Medicare.
    Shaya FT; Breunig IM; Seal B; Mullins CD; Chirikov VV; Hanna N
    Pharmacoeconomics; 2014 Jan; 32(1):63-74. PubMed ID: 24293197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in Discharge Disposition Following Hepatectomy for Hepatocellular Carcinoma Among Medicare Beneficiaries.
    Dalmacy DM; Hyer JM; Diaz A; Paro A; Tsilimigras DI; Pawlik TM
    J Gastrointest Surg; 2021 Nov; 25(11):2842-2850. PubMed ID: 33821414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of five-year survival among patients with hepatocellular carcinoma in the United States: an analysis of SEER-Medicare.
    Zhang X; El-Serag HB; Thrift AP
    Cancer Causes Control; 2021 Apr; 32(4):317-325. PubMed ID: 33394207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative imaging surveillance for hepatocellular carcinoma: How much is enough?
    Mirdad RS; Madison Hyer J; Diaz A; Tsilimigras DI; Azap RA; Paro A; Pawlik TM
    J Surg Oncol; 2021 Jun; 123(7):1568-1577. PubMed ID: 33596330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Payer-Negotiated Price Variation and Relationship to Surgical Outcomes for the Most Common Cancers at NCI-Designated Cancer Centers.
    Sankaran R; O'Connor J; Nuliyalu U; Diaz A; Nathan H
    Ann Surg Oncol; 2024 Jul; 31(7):4339-4348. PubMed ID: 38506934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.